Health News

Rx May Keep Kids With ADHD Safe
A common medication for ADHD may keep kids out of the emergency room.
Tetraphase Announces Positive Top-line Results from Phase 3 IGNITE 1 Clinical Trial of Eravacycline in Complicated Intra-abdominal Infections
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced positive top-line results from IGNITE 1, the Company's Phase 3 clinical trial of eravacycline for the treatment of complicated intra-abdominal infection (cIAI) compared to ertapenem.
E-Cigs More Common Than Cigarettes Among Teens
Traditional cigarette smoking has been dropping among US teens for years. But there might be a new trend to consider — e-cigarettes.
Know Your Rx — It May Help Your Recovery
Understanding what a medication does and how to use it properly may be as important to your health as actually taking the pill.
Early Caregiving Boosted Babies' Development
Mothers who quickly respond to that 3 a.m. feeding wail with love and attention may improve their children’s development — from infancy to adulthood.
Asthma Inhalers, Allergy Devices Could Save Lives
In a severe allergy attack, patients may need to take medication fast — and using medication incorrectly could slow this process. Many patients may need more education on how to use their medications properly.
Blackouts After Boozing All Too Common in Teens
Families and schools can take steps to stop the risky business of teen drinking. Teens are one of the groups most prone to binge drinking — a practice that can lead to alcohol-related blackouts.
Live Long and Prosper: Global Wellness Increased
Good news for the people of Earth: people are living much longer than they were 20 years ago, and death rates have dropped for certain cancers, heart disease, stroke and other major diseases around the world.
Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy
Pfizer Inc. (NYSE:PFE) announced today enrollment of the first patient in a multicenter Phase II clinical trial of the investigational compound PF-06252616 in boys with Duchenne muscular dystrophy (DMD), a genetic disorder characterized by progressive muscle degeneration and weakness. PF-06252616 is an experimental, infused, anti-myostatin monoclonal antibody.
FDA Approves Xtoro to Treat Swimmer’s Ear
The U.S. Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used to treat acute otitis externa, commonly known as swimmer’s ear.
<< first308309310311312313314315316last >>

REFINE